{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:45:01Z","timestamp":1780422301897,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare, Taiwan","doi-asserted-by":"publisher","award":["DOH101-HP-1103"],"award-info":[{"award-number":["DOH101-HP-1103"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare, Taiwan","doi-asserted-by":"publisher","award":["DOH102-HP-1103"],"award-info":[{"award-number":["DOH102-HP-1103"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare, Taiwan","doi-asserted-by":"publisher","award":["MOHW103-HPA-H-114-134101"],"award-info":[{"award-number":["MOHW103-HPA-H-114-134101"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare, Taiwan","doi-asserted-by":"publisher","award":["MOHW104-HPA-H-114-134101"],"award-info":[{"award-number":["MOHW104-HPA-H-114-134101"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejim.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T07:59:29Z","timestamp":1475827169000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Simultaneous control of glycemic, blood pressure, and lipid significantly reduce the risk of renal progression in diabetes patients"],"prefix":"10.1016","volume":"36","author":[{"given":"Po-Ya","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Nien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ta","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yi","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2016.09.013_bb0005","first-page":"90","article-title":"The prevalence and risk factors of diabetic nephropathy in Taiwanese type 2 diabetes \u2014 a hospital based study","volume":"23","author":"Shen","year":"2009","journal-title":"Acta Nephrol"},{"key":"10.1016\/j.ejim.2016.09.013_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119699","article-title":"Elevated serum levels of mannose-binding lectin and diabetic nephropathy in type 2 diabetes","volume":"10","author":"Guan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2016.09.013_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","article-title":"Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy","volume":"30","author":"Elmarakby","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ejim.2016.09.013_bb0020","first-page":"S1","article-title":"Standards of medical care diabetes\u20142015","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2016.09.013_bb0025","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00125-014-3160-9","article-title":"Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007\u20132011","volume":"57","author":"Assogba","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejim.2016.09.013_bb0030","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2016.09.013_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2016.09.013_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s13410-013-0114-6","article-title":"The risk factors of diabetic nephropathy in Taiwan, including old age, hypertension and aspirin therapy","volume":"33","author":"Cheng","year":"2013","journal-title":"Int J Diabetes Dev C"},{"key":"10.1016\/j.ejim.2016.09.013_bb0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.ackd.2014.03.009","article-title":"Epidemiology and risk factors for diabetic kidney disease","volume":"21","author":"Harjutsalo","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ejim.2016.09.013_bb0050","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2016.09.013_bb0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2016.09.013_bb0065","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00125-008-0990-3","article-title":"Long-term prevention of diabetic nephropathy: an audit","volume":"51","author":"Schjoedt","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejim.2016.09.013_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2337\/dc13-2023","article-title":"Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy","volume":"37","author":"Lithovius","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2016.09.013_bb0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group","volume":"317","author":"Prospective","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2016.09.013_bb0080","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2337\/diacare.20.6.999","article-title":"Determinants of progression of microalbuminuria in patients with NIDDM. A prospective study","volume":"20","author":"Smulders","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2016.09.013_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejim.2016.09.013_bb0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/CIRCOUTCOMES.111.963553","article-title":"Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems","volume":"5","author":"Schroeder","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejim.2016.09.013_bb0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2008.09.047","article-title":"Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006","volume":"122","author":"Cheung","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/jama.299.14.1678","article-title":"Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial","volume":"299","author":"Howard","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2016.09.013_bb0105","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ejim.2016.09.013_bb0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2016.09.013_bb0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/07315724.2011.10719974","article-title":"Central obesity predicts non-Hodgkin's lymphoma mortality and overall obesity predicts leukemia mortality in adult Taiwanese","volume":"30","author":"Chu","year":"2011","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.ejim.2016.09.013_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2215\/CJN.05600612","article-title":"Factors associated with CKD in the elderly and nonelderly population","volume":"8","author":"Lin","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2016.09.013_bb0130","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.2337\/dc09-0694","article-title":"Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome, and chronic kidney disease in Taiwanese","volume":"32","author":"Lin","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2016.09.013_bb0135","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1047-2797(03)00066-8","article-title":"Lifestyle risk factors and chronic kidney disease","volume":"13","author":"Vupputuri","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ejim.2016.09.013_bb0140","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/ndt\/gfh470","article-title":"Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria","volume":"19","author":"Gaede","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2016.09.013_bb0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2016.09.013_bb0150","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2337\/dc09-0959","article-title":"Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial","volume":"32","author":"Zoungas","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2016.09.013_bb0155","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0165","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"de Boer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002051","article-title":"Nonadherence of oral antihyperglycemic medication will increase risk of end-stage renal disease","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2016.09.013_bb0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","article-title":"Blood pressure predicts risk of developing end-stage renal disease in men and women","volume":"41","author":"Tozawa","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2016.09.013_bb0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinte.165.8.923","article-title":"Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease","volume":"165","author":"Hsu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ki.2013.103","article-title":"Adherence to antihypertensive agents improves risk reduction of end-stage renal disease","volume":"84","author":"Roy","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2016.09.013_bb0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa013410","article-title":"Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes","volume":"347","author":"Lurbe","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.1994.03510280037029","article-title":"Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group","volume":"271","author":"Viberti","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2016.09.013_bb0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)39898-9","article-title":"Molecular physiology of reverse cholesterol transport","volume":"36","author":"Fielding","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2016.09.013_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1874192400701010008","article-title":"Statin-induced increase in HDL-C and renal function in coronary heart disease patients","volume":"1","author":"Athyros","year":"2007","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.ejim.2016.09.013_bb0210","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2016.09.013_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10157-004-0332-9","article-title":"Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort","volume":"9","author":"Iseki","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ejim.2016.09.013_bb0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.11.036","article-title":"Continuation of statin therapy and a decreased risk of atrial fibrillation\/flutter in patients with and without chronic kidney disease","volume":"232","author":"Chang","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2016.09.013_bb0225","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1093\/ndt\/gfl244","article-title":"The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study","volume":"21","author":"Atthobari","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2016.09.013_bb0230","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4065\/82.11.1381","article-title":"Effects of statins on renal function","volume":"82","author":"Agarwal","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2016.09.013_bb0235","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5551\/jat.3764","article-title":"Effects of pitavastatin (LIVALO tablet) on the estimated glomerular filtration rate (eGFR) in hypercholesterolemic patients with chronic kidney disease. Sub-analysis of the LIVALO effectiveness and safety (LIVES) study","volume":"17","author":"Kimura","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ejim.2016.09.013_bb0240","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamainternmed.2013.12700","article-title":"Renoprotective effect of renin\u2013angiotensin\u2013aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia","volume":"174","author":"Hsu","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ackd.2014.03.005","article-title":"Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease","volume":"21","author":"Yamout","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.ejim.2016.09.013_bb0255","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2016.09.013_bb0260","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.amjhyper.2006.05.011","article-title":"Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes","volume":"19","author":"Estacio","year":"2006","journal-title":"Am J Hypertens"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516303144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516303144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T22:10:31Z","timestamp":1657404631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516303144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":51,"alternative-id":["S0953620516303144"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.09.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous control of glycemic, blood pressure, and lipid significantly reduce the risk of renal progression in diabetes patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}